EMERGING ANTIMICROBIALS AND DIAGNOSTICS in AMR: 26/27 NOV 2024

Search for:

Home » _News » Smart Innovations » Page 11

AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.

Towards the sustainable discovery and development of new antibiotics

LSHTM launches new centre of innovation to tackle antimicrobial resistance and tuberculosis

JPIAMR-VRI Digital Platform

Microfluidic filter device coupled mass spectrometry for rapid bacterial antimicrobial resistance analysis

AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

Integrating programmable DNAzymes with electrical readout for rapid and culture-free bacterial detection using a handheld platform

Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics

Brexit will not end scientific collaboration between the UK and EU

The AMR Action Fund is combating antimicrobial resistance, but much more action is needed

Congress needs to fix the broken market for antibiotic development

New Technique Enables Quick Identification of Potential Drugs to Fight Antibiotic-Resistant Bacteria

Qpex Biopharma Initiates Phase 1 Study of QPX9003 Targeting Antibiotic-Resistant Pathogens

New Web Tool Fights Antibacterial Resistance

A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile

Predicting Antimicrobial Resistance Using Partial Genome Alignments

Renewed Introduction of the PASTEUR Act Returns AMR to National Agenda

Interdisciplinary GW4 AMR Alliance is to become the UK’s leading ‘One Health’ AMR research consortium, recognised globally

Hope amid challenging times for antibiotic developers

Biotechs are saving the world from superbugs. Can they also save themselves?

Experimental vaccine forces bacteria down an evolutionary dead end

EPSRC funding announced to tackle resistance to antibiotics

Urgent Action Needed to Spur Antibiotic Innovation

GARDP Receives Funding From the Government of Japan as Part of Its Ongoing Contribution To Fight Against Drug-Resistant Infections

CARB-X IS FUNDING ACCELERATE DIAGNOSTICS TO DEVELOP A RAPID OPTICAL IMAGING DIAGNOSTIC FOR SEPSIS AND SERIOUS ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS

Trained viruses prove more effective at fighting antibiotic resistance

Novel tool to visualize antibiotic resistance

The plot thickens: data visualization in antimicrobial resistance research

Adaptive Phage Therapeutics Initiates Phase 1/2 Trial of PhageBank™ in Urinary Tract Infections

SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Nanotherapeutics Hub joins iiCON to help strengthen UK’s infectious disease products pipeline

CARB-X IS FUNDING SWISS PHARMA COMPANY BIOVERSYS TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT INFECTIONS CAUSED BY MULTIDRUG-RESISTANT ESKAPE PATHOGENS

Fight Against Antibiotic-Resistant Bacteria Has a Glowing New Weapon

Drug-resistant Staphylococcus Aureus Bacteria Detection with the Combination of Surface-enhanced Raman Spectroscopy and Deep Learning Techniques

Liverpool platform will support nanomedicine developers

Mathematical model predicts effect of bacterial mutations on antibiotic success

CARB-X IS FUNDING SNIPR BIOME TO DEVELOP A CRISPR-ENGINEERED DRUG TO ERADICATE ESCHERICHIA COLI (E. COLI) BACTERIA IN CANCER PATIENTS TO PREVENT DEADLY INFECTIONS

WHO and Switzerland launch global BioHub for pathogen storage, sharing and analysis

Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit

Innovation from Halton and LED Tailor – a disinfection blue light system that kills microbes in operating rooms and brings hope to the antibiotic resistance fight in the hospitals

U.K. Pitches Radical Investment Plans to Fight Killer Bacteria

TGAR Foundation and AMR Insights to join forces

Three-Dimensional Micropatterning Deters Early Bacterial Adherence and Can Eliminate Colonization

Study identifies colistin resistance drug target

CARB-X IS FUNDING BASILEA PHARMACEUTICA TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA

Deciphering Potential Roles of Earthworms in Mitigation of Antibiotic Resistance in the Soils from Diverse Ecosystems

Analyzing Empirical Quality Metrics of Deep Learning Models for Antimicrobial Resistance

CARB-X IS FUNDING SUMMIT THERAPEUTICS TO DEVELOP A NEW ANTIBIOTIC TO TREAT MULTIDRUG-RESISTANT INFECTIONS CAUSED BY CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE)

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed